Regulatory
PHN-0001
2026-10-30 14:05 CT
FDA updates its list of bulk substances under compounding review
FDA.gov
The agency posted a revised list of bulk drug substances and their compounding categories.
NoticeInformation only. Not medical advice. Nothing here is a recommendation to use any substance. Read full disclaimer
3 items
Featured
FDA.gov
The agency posted a revised list of bulk drug substances and their compounding categories.
Journal preprint
Authors identify few controlled human studies among largely preclinical literature.
WADA
Testing bodies note an increase in adverse findings involving unapproved peptides.